Danaher stock set for November healthcare conference appearances

Danaher said on Monday, November 2, that President and Chief Executive Officer Julie Sawyer Montgomery will present at the UBS Global Healthcare Conference and the Jefferies Global Healthcare Conference. The announcement was published in the company's investor relations press release archive.

The appearances put Danaher's senior leadership on the agenda at two major healthcare investor gatherings in November. For shareholders, the events offer a potential setting for management commentary on demand across bioprocessing, life sciences and diagnostics after the company's third-quarter results.

Management focus after third quarter

Danaher reported third-quarter 2026 revenue of 6.554 billion US dollars and net income of 1.235 billion US dollars, according to a recent company update cited in market coverage. The results kept attention on operating execution while respiratory testing remained a pressure point for reported growth.

The conference schedule does not itself change Danaher's earnings outlook or establish a new financial target. It does, however, give investors a near-term opportunity to assess how the new chief executive frames growth, portfolio priorities and the recovery in the company's core businesses.

The real-time quote of Danaher stock traded at 200.30 euros on Lang & Schwarz at 13:39 CET on Friday, November 6, 2026. The quote provides a live market indication as investors weigh the upcoming appearances and the company's recent results.

The S&P 500 provides the broader US equity-market backdrop for Danaher's investor audience; current market coverage tracks that setting.

Further developments can emerge when Montgomery addresses investors at the two conferences. More news and analyses on Danaher stock will follow the company's public communications.